A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Our study found that doing these kinds of screenings on patients doesn't make any marked difference in their long-term survival rates." J. Brent Muhlestein, principal investigator of the study and ...

The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell ...

In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

As fears of a potential conflict with Russia grow, Sweden is distributing leaflets among its citizens with clear instructions ...

In reflecting on education and training authority for the agriculture sector AgriSETA’s accomplishments for the 2023/24 ...

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan ...

First in six years is nearly three times the size of the older, pre-NATO version Residents of Sweden are to receive a handy new guide this week that details how to prepare for various types of crisis ...